Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival
Authors:
Open Access
- 15 September 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11
Abstract
Background: Limited treatment strategies are available for squamous-cell lung cancer (SQLC) patients. Few studies have addressed whether immune-related genes (IRGs) or the tumor immune microenvironment can predict the prognosis for SQLC patients. Our study aimed to construct a signature predict prognosis for SQLC patients based on IRGs. Methods: We constructed and validated a signature from SQLC patients in The Cancer Genome Atlas (TCGA) using bioinformatics analysis. The underlying mechanisms of the signature were also explored with immune cells and mutation profiles. Results: A total of 464 eligible SQLC patients from TCGA dataset were enrolled and were randomly divided into the training cohort (n = 232) and the testing cohort (n = 232). Eight differentially expressed IRGs were identified and applied to construct the immune signature in the training cohort. The signature showed a significant difference in overall survival (OS) between low-risk and high-risk cohorts (P < 0.001), with an area under the curve of 0.76. The predictive capability was verified with the testing and total cohorts. Multivariate analysis revealed that the 8-IRG signature served as an independent prognostic factor for OS in SQLC patients. Naive B cells, resting memory CD4 T cells, follicular helper T cells, and M2 macrophages were found to significantly associate with OS. There was no statistical difference in terms of tumor mutational burden between the high-risk and low-risk cohorts. Conclusion: Our study constructed and validated an 8-IRG signature prognostic model that predicts clinical outcomes for SQLC patients. However, this signature model needs further validation with a larger number of patients.Keywords
Funding Information
- National Natural Science Foundation of China (81973775)
This publication has 45 references indexed in Scilit:
- Neuropilin 1 guides regulatory T cells into VEGF-producing melanomaOncoImmunology, 2013
- Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking StatusPLOS ONE, 2012
- Targeting NR4A1 (TR3) in cancer cells and tumorsExpert Opinion on Therapeutic Targets, 2010
- Comparison of lung cancer cell lines representing four histopathological subtypes with gene expression profiling using quantitative real-time PCRCancer Cell International, 2010
- The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III StudiesThe Oncologist, 2009
- Leptin Receptor–Related Immune Response in Colorectal Tumors: The Role of Colonocytes and Interleukin-8Cancer Research, 2008
- Selection of important variables and determination of functional form for continuous predictors in multivariable model buildingStatistics in Medicine, 2007
- CGA Gene (Coding for the α Subunit of Glycoprotein Hormones) Overexpression in ERα-Positive Prostate TumorsEuropean Urology, 2002
- The CGA gene as new predictor of the response to endocrine therapy in ERα-positive postmenopausal breast cancer patientsOncogene, 2001
- Characterization of a germline Vk gene encoding cationic anti-DNA antibody and role of receptor editing for development of the autoantibody in patients with systemic lupus erythematosus.Journal of Clinical Investigation, 1996